-
Staying Safe: The Importance of Medication Monitoring as the Pandemic Continues
The COVID-19 pandemic continues to pose significant challenges to the healthcare system, despite widespread availability of vaccines. Variants of the virus…
-
Cases of Unusual Buprenorphine Concentrations in Urine Drug Tests: What Does This Mean and Clinical Implications?
Buprenorphine is a semisynthetic opioid with partial agonist activity at the mu-opioid receptor, an effective treatment option for opioid use disorder…
-
NPS Focus: “Nitazene" Synthetic Opioids
Aegis launched an extensive and industry-leading testing menu of Novel Psychoactive Substances (NPS) in mid-2020, which includes phenibut, tianeptine,…
-
Finding Fentanyl
Synthetic opioids, including fentanyl, buprenorphine, meperidine, methadone and others,1 comprise a class of drugs manufactured in laboratories designed…
-
Interpretation of Buprenorphine and Naloxone Results: Considerations for Dosage Form and Specimen Type
Buprenorphine prescribing is extremely common across multiple clinical specialties, primarily opioid use disorder (OUD) and pain management treatment providers. …
-
NPS Focus: Designer Benzodiazepines
Aegis launched an extensive and industry-leading testing menu of Novel Psychoactive Substances (NPS) in mid-2020, which includes designer benzodiazepines,…
-
Expansion of Urine Behavioral Health Drug Testing, AcuRiseID™
Aegis Sciences Corporation, a leading healthcare company that provides innovative medication adherence testing, is pleased to announce the expansion of…